Here’s what you should know.
1. Researchers use the biomarkers to test the effectiveness of Cetuximab, a drug which blocks the receptor for the epidermal growth factor, and 5FU, a chemotherapy drug.
2. Berlin, Germany-based Charite University Hospital and University Hospital Graz (Austria) researchers collected tumor samples from more than 100 colorectal cancer patients.
3. The researchers analyzed the tumors defining the RNA molecules in a given tissue to produce the cancer’s biomarkers
4. By establishing biomarkers, scientists can better engineer treatments that’ll combat bowel cancer.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. David Carron of GI Associates
Allergan’s Q4 beats analysts’ estimates: 4 insights
Dr. Democleia Panagou Gottesman named ‘Leading Physician of the World’ — 4 key notes
